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Abstract
Peptide libraries or antigenic determinants can be displayed on the surface of bacteria through insertion in a suitable outer
membrane scaffold protein. Here, we inserted the well-known antibody epitopes 3xFLAG and 2xmyc in exterior loops of the
transmembrane (TM) domain of OmpA. Although these highly charged epitopes were successfully displayed on the cell
surface, their levels were 10-fold reduced due to degradation. We verified that the degradation was not caused by the
absence of the C-terminal domain of OmpA. In contrast, a peptide that was only moderately charged (SA-1) appeared to be
stably incorporated in the outer membrane at normal protein levels. Together, these results suggest that the display
efficiency is sensitive to the charge of the inserted epitopes. In addition, the high-level expression of OmpA variants with
surface-displayed epitopes adversely affected growth in a strain dependent, transient manner. In a MC4100 derived strain
growth was affected, whereas in MC1061 derived strains growth was unaffected. Finally, results obtained using a gel-shift
assay to monitor b-barrel folding in vivo show that the insertion of small epitopes can change the heat modifiability of the
OmpA TM domain from ‘aberrant’ to normal, and predict that some b-barrels will not display any significant heat-
modifiability at all.
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Introduction
Bacterial surface display is widely used to screen peptide libraries
for e.g. epitope mapping and selection of high affinity binders [1].
As differences in display efficiency among different clones could
cause unwanted biases during the selection process, knowledge of
the capabilities, as well as the limitations of the particular display
scaffold used, is considered to be of importance [2].
One such scaffold is the OmpA protein in Escherichia coli. OmpA
is an integral outer membrane protein (OMP) embedded in the
bacterial outer membrane (OM) as a b-barrel. It contains four
surface exposed loops in which peptides can be inserted that
subsequently are displayed on the cell surface [3]. Several reports
exist in which the OmpA protein has been used as a bacterial
surface display system, for applications such as peptide library
screening [4,5] use in a novel selection strategy [6], use as live
vaccines [7] or to sequestrate cadmium for bioremediation [8].
The full-length, processed OmpA protein (325 residues) consists
of two domains, a N-terminal transmembrane (TM) domain of
170 residues, connected via a short 19-residue Ala-Pro rich hinge
region to a C-terminal periplasmic domain of 136 residues [9].
The periplasmic domain plays a structural role by tethering the
OM to the peptidoglycan cell wall layer. However, genetically
truncated OmpA-171 consisting of only the TM domain assembles
into the outer membrane as efficiently as the full-length protein
[10]. For a comprehensive review on OmpA structure and
function see [11].
Ourgoalwasto displayan epitope on the bacterialcellsurface that
couldberecognized by commerciallyavailableantibodies and used as
a handle in biophysical force experiments (to be published elsewhere).
OmpA was chosen because it is very abundant (typically about 10
5
copies/cell (Koebnik et al. 2000)) and widely studied [12,13]. For our
biophysical application, adverse effects of peptide-insertion on protein
levels or OM insertion were unwanted. Because epitope-sized
insertions in loop 2 or 4 of OmpA have been shown to be tolerated
without negative effects [3], this served as an additional reason to
chooseOmpA. Thus, we have inserted the epitope tags 3xFLAG and
2xmyc into loop 2 and 3 of the transmembrane domain of OmpA
(here also referred to as OmpA-177), and studied their stability and
outer membrane incorporation in vivo. As the cell wall anchoring by
the periplasmic domain was unwanted in these experiments, the TM
domain of OmpA was initially used instead of the full-length protein.
We show that these engineered OmpA TM domain variants can
be incorporated into the OM and that the epitopes are successfully
displayed on the cell surface. To our surprise however both are
present at roughly 10-fold reduced levels compared to the b-barrel
without epitope due to degradation. Since to our knowledge, all in
vivo loop insertions to date have been made in full-length OmpA, we
investigated a possible stabilizing role of the periplasmic domain.
Our data demonstrate that the periplasmic domain did not stabilize
the 3xFLAG insertion variants. These results suggest an incompat-
ibility of 3xFLAG and 2xmyc tags with the OM biogenesis pathway
of OmpA. In the end, we created an OmpA insertion variant that
met our requirements by truncating a full length OmpA containing
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peptides [5]. The results obtained withthis variant demonstrate that
it is possible to display a peptide in the OmpA b-barrel without
negative effects on protein levels or OM insertion. Together, these
results suggest that the display efficiency is sensitive to the charge of
the inserted epitope, as both 2xmyc (20-mer) and 3xFLAG (22-mer)
are highly charged (50% and 70% charged residues, respectively)
whereas the SA-1 peptide (15-mer) is moderately charged,
containing only 2 charged residues.
In addition, we report that the high-level expression of epitope-
containing OmpA constructs had a strong, transient, negative
effect on the cellular growth rate that was strain dependent. In a
MC4100 (a standard E. coli laboratory strain) derivative, growth
rate was transiently impaired, whereas in strain MC1061 as well as
a DOmpA MC1061 derivative no detrimental effects were
observed. This suggests that when over-expressing outer mem-
brane proteins, MC1061 is a strain of choice.
To test for outer membrane incorporation, we make use of
OmpA’s so-called heat modifiability [14]. In its folded form,
OmpA migrates to a different position in SDS-PAGE compared
to its (heat denatured) unfolded form [15]. Whereas for full
length OmpA, the folded form migrates faster through the gel,
for the transmembrane domain of OmpA it is the other way
around [10]. This was termed ‘aberrant heat modifiability’ [10].
We show that small epitope insertions in the transmembrane
domain restore normal heat modifiability, and this observation
predicts that some b-barrels might not exhibit any heat
modifiability at all.
Materials and Methods
Bacterial strains and growth conditions
E. coli strains (Table 1) were grown at 37uC in TY medium
containing 1% Bacto trypton, 0.5% Bacto yeast extract, 0.5%
NaCl and 3 mM NaOH. Expression of the constructs was induced
by adding up to 1 mM IPTG or 0.02% L-arabinose, depending on
the plasmid vector. Antibiotics were ampicillin (100 mg/ml) or
Chloramphenicol (25 mg/ml). LMC500 (MC4100 lysA) was made
chemically competent using the calcium chloride method.
MC1061 and its derivative MC1061 DOmpA were transformed
using electroporation.
Constructs
All constructs (Table 1) were cloned into a pTrc99A vector
(Pharmacia Biotech, USA), a pBR322 derivative plasmid, of which
the trc promoter was modified with a down mutation to reduce
expression levels [16]. All DNA manipulation, analysis and
bacterial transformations were performed according to standard
protocols (Sambrook et al., 1989). All PCR fragments were
sequenced, either at Baseclear (Leiden) or at the AMC DNA
sequencing facility (Amsterdam Medical Centre). Primers were
ordered from MWG or Biolegio, and Advantage DNA polymerase
(Clontech) or pfuTurbo DNA polymerase (Stratagene) was used for
the PCR reactions. The cloning steps performed to obtain the
plasmids are described in the Materials and Methods S1.
Preparation of cell lysates
Fresh overnight cultures grown at 37uC were diluted 1000x into
50–100 ml fresh TY medium and cultured at 37uC. Growth was
monitored by measurement of the optical density at 600 nm with a
spectrophotometer (Perkin-Ellmers). IPTG was added at around
an OD600 of 0.1, and when the cells reached an OD600 of 1.0,
they were transferred to a 50 ml Falcon tube and put on ice. The
cells were then collected by centrifugation for 15 min at 4000 rpm
in a tabletop centrifuge at 4uC (Eppendorf). The supernatant was
carefully removed, and the cells were resuspended in ice-cold
sonication buffer (10 mM Tris-HCl buffer, pH 7.9, supplemented
with 1 mM EDTA and 1 tablet of Roche Protease Inhibitor
Table 1. Strains and plasmids used in this study.
Strains Genotype Reference
LMC500 (MC4100 lysA)F
2, araD139, D(argF-lac)U169, deoC1, flbB5301, ptsF25, rbsR, relA1, rpslL150, lysA1 [20]
MC1061 F
2, araD139, D(ara-leu)7696, DlacX74, galE, galK, hsdR2 (rk2 mk+), mcrA0, mcrB1, rpsL, spoT1, relA1 [22,38]
MC1061 DOmpA MC1061 DOmpA [5]
DH5a F
2, endA1, hsdR17(rk2 mk+), supE44, thi-1, recA1, gyrA, relA1, D(lacZYA-argF)U169, deoR, W80 lacZDM15 Lab collection
DH5a-Z1 DH5a LacIq
+ TetR
+ [39]
Plasmids Proteins expressed Reference
pMD005 pTHV037 OmpA-177 This work
pGV1 pTHV037 OmpA-177 2xmyc in Loop 2 This work
pGV2 pTHV037 OmpA-177 3xFLAG in Loop 2 This work
pGV3 pTHV037 OmpA-177 2xmyc in Loop 3 This work
pGV4 pTHV037 OmpA-177 3xFLAG in Loop 3 This work
pGI9 pTHV037 OmpA-LEDPPAEF This work
pGI6 pTHV037 OmpA-LEDPPAEF containing 3xFLAG in Loop 3 This work
pB33OmpA14-SA1 pBAD33 OmpA SA-1 in Loop 1 [5]
pGV28 pTHV037 OmpA-177-SS SA-1 in Loop 1 This work
pGV32 pTHV037 OmpA-LEDPPAEF 3xFLAG in Loop 2 This work
pGV33 pTHV037 OmpA-LEDPPAEF SA-1 in Loop 1 OmpA-177 This work
pTHV037 pTRC99A with a weakened IPTG inducible promoter [16]
doi:10.1371/journal.pone.0006739.t001
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This cell suspension was transferred to a 2 ml Eppendorf tube, and
sonicated on ice with a tip sonicator (Branson) in 4–5 10-second
bursts with 10 second cooling in between each burst. Debris and
intact cells were pelleted in a 4uC cooled centrifuge at 2700 x g for
2 min. The supernatant was transferred to a 1.5 ml Eppendorf
tube and frozen at 220uC as total cell lysate.
Fractionation of cell lysates
After thawing, the cell lysate was diluted to 4 ml (corresponding
to an OD600 of 12.5), and 100 ml of this was saved as ‘‘total cell
lysate’’. The samples were pelleted at 45000 rpm (corresponding
to 200.000 x g) for 45 min in an ultracentrifuge (Beckman-
Coulter). After centrifugation, 500 ml was saved as ‘‘supernatant’’.
The membrane pellet was resuspended in 100 ml sonication buffer
and frozen at 220uC.
SDS-PAGE and Western blotting
For SDS-PAGE, samples were mixed with sample buffer (end
concentration: 62.5 mM Tris pH 6.8, 2% SDS, 10% glycerol, 2%
2-mercaptoethanol) and either heated to 99uC for 5 min or heated
to 50uC for 15 min and electrophoresed on 15% polyacrylamide
slabs. Anti-FLAG and anti-myc monoclonal antibodies used for
the immunoblots were obtained from Sigma and Roche,
respectively. The polyclonal anti-OmpA antibody was a kind gift
from A. Driessen (University of Groningen, Netherlands). The
bands were detected using the ECL+ chemiluminescence kit
(Amersham) and scanning with a STORM 860 fluorescence
imager. Densitometry was performed using ImageJ (http://rsb.
info.nih.gov/ij/). The mean pixel value of a rectangular region
was calculated close but outside a band of interest to calculate the
mean background pixel value. The same selection rectangle was
positioned to include the band of interest, and again a mean pixel
value is calculated. Subtraction then gives a band intensity value.
All band comparisons were performed using the same selection
rectangle.
Fluorescent labeling of fixed cells
Cells were fixed in 2.8% formaldehyde (FA) and 0.04%
glutaraldehyde (GA) in growth medium for 15 min at room
temperature, then washed and resuspended in PBS (140 mM
NaCl, 27 mM KCl, 10 mM Na2HPO4?2H2O, 2 mM KH2PO4
pH 7.2). Cell concentration was adjusted to an OD600 of 0.6 and
samples were incubated in 75 ml PBS containing 30 mg/ml BSA
to block non-specific sites on the cell surface for 30 min at 37uC.
Then antibodies were added, either anti-FLAG (M2, Sigma) or
anti-myc (9E10, Roche) at an end concentration of 20 mg/ml, and
samples were incubated at 37uC for 30 min. The cells were
washed 3 times with 2 volumes of PBS containing 30 mg/ml BSA,
and then incubated in 1 volume with Donkey-anti-Mouse-Cy3
conjugate (Jackson ImmunoResearch) at 10 mg/ml end concen-
tration for 30 min at 37uC, washed 3 times with 2 volumes PBS
and imaged.
Fluorescent labeling of living cells
Cells were put on ice, and an amount of cells equivalent to 1 ml
OD600 of 0.3 (around 2?10
8 cells) was taken for labeling. Cells
were collected in all cases by centrifugation at 20.000 x g for 5 min
at 4uC. The pellet was resuspended in 75 ml PBS at room
temperature (RT) with 0.1% BSA. The cells are left at RT for
10 min to block aspecific sites on the cell surface. Then either
biotinylated anti-FLAG (Sigma) was added (50 mg/ml) (FLAG
constructs), or streptavidin-Alexa 488 (Molecular Probes) was
added directly (40 mg/ml) (SA-1 constructs). Cells were incubated
at RT for 30 min. The cells were spun down and washed twice
with 0.5 ml PBS, and resuspended in 150 ml PBS. For the cells
labeled with biotinylated FLAG, streptavidin-Alexa 546 (Molec-
ular Probes) was added (5 mg/ml), and samples were incubated for
30 min at RT. Then, PBS (0.85 ml) was added and the cells were
pelleted. After a second wash with 0.5 ml PBS, the cells were fixed
in 1 ml PBS with 2.8% formaldehyde and 0.042% glutaraldehyde,
washed in 1 volume of PBS and resuspended in 0.1 volume PBS.
The cells were either imaged directly or stored at 4uC over night
before imaging.
Fluorescence Microscopy
Cells were immobilized on 1% agarose in water slabs-coated
object glasses as described by [17] and photographed with a
CoolSnap fx (Photometrics) CCD camera mounted on an
Olympus BX-60 fluorescence microscope through a UPLANFl
100x/1.3 oil objective (Japan). Images were taken using the public
domain program Object-Image2.19 by Norbert Vischer (Univer-
sity of Amsterdam, http://simon.bio.uva.nl/object-image.html),
which is based on NIH Image by Wayne Rasband. In all
experiments the cells were first photographed in the phase contrast
mode. Then a fluorescence image was taken using either a green
excitation/red emission (U-MNG, ex. 530–550 nm), or a blue
excitation/green emission filter cube (U-MNB or EGFP, ex. 470–
490 nm).
Results
Design of loop insertions
A topology model of the transmembrane domain of OmpA is
shown in Figure 1. For locations in loop 2 and loop 4 (after Y63,
G70 and I153 respectively), it has been shown that small (up to 21
residue) peptides can be inserted without any reduction in protein
levels [3,18] and membrane incorporation (after G70 and I153,
[3]). For loop 2, reported inserted peptides are listed in Table 2.
Initially, we used only the OmpA TM domain, but later also the
periplasmic domain was added. 3xFLAG and 2xmyc peptides
were chosen as epitope tags (Table 2). We will refer to them as
FLAG and myc from now on. High-affinity monoclonal
antibodies are commercially available for these epitopes.
SWISS-Model [19] was used to predict OmpA folding after
peptide insertion. First, a continuous model was generated of the
first 176 residues, based on the published crystal structures of
OmpA-171 (Figure S1A). Then, models were generated of loop
insertions after different residues in the protein, and the resulting
(static) loop conformations were examined for their propensity to
extend away from the membrane normal axis. Models were
generated of insertions in loop 2, 3 and 4. Finally, loop 3 was
chosen, since the computer-generated model of an inserted
FLAG peptide after N109 predicted the largest distance away
from the surface (Figure S1C).
To be able to compare the performance of our constructs with
results reported in literature, we also constructed loop 2 insertions
with the FLAG and myc epitopes. For loop 2, insertions after G65,
G70, Y72 and Q75 were modeled. In the end G70 was chosen,
because (a) as mentioned, it was shown that at this location, a 21-
residue peptide could be inserted without any negative effects on
membrane insertion [3], and (b) modeling with SWISS-Model of
these four locations predicted that at G70, the loop would be
extended away from the surface more than at the other three
positions in loop 2 (Figure S1B).
During the course of this work, a loop 1 peptide insertion (SA-1
tag) in full-length OmpA was described in the literature [5]. The
Differential Surface Display
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mentioned in the introduction, the SA-1 peptide tag (listed in
Table 2) binds streptavidin directly with high affinity. Since this
peptide was neutrally charged and could be conveniently labeled
with fluorescent streptavidin, we decided to compare this loop
insertion variant with our constructs. Therefore, it was cloned into
our expression vector, both as a truncated OmpA consisting only
of the TM domain and as a full-length protein, and assayed in the
same way as the FLAG/myc insertions.
Growth of cells expressing OmpA-177 loop insertion
proteins
The constructs were tested for expression in LMC500 (MC4100
lysA), a well characterized laboratory strain [20,21], MC1061
DOmpA [5], an OmpA knockout strain, and in its parental strain
MC1061 [22]. To test to what extent the proteins could be
expressed without affecting the growth rate, the growth was
followed by measuring the optical density before and after addition
of the inducer IPTG. Growth curves from a typical experiment are
shown in Figure 2. In this experiment, cells carrying an empty
vector were compared with cells expressing an OmpA-177 protein
with a FLAG insertion either in loop 2 or loop 3. Without IPTG
induction, all growth curves appear identical. Approximately 15
minutes after addition of IPTG however, the OmpA-177 protein
with a FLAG insertion in loop 2 shows a lag phase where growth
stops for approximately 30 min, after which growth continues
normally. In contrast, for the growth curve of the OmpA-177
variant containing a FLAG insertion in loop 3, no lag phase is
Figure 1. Topology model of the TM domain of OmpA (OmpA-177) (adapted from [40]). Black arrowheads indicate positions where
peptides have been inserted: after N26 [5] and this study, Y63 [18], G70 [3] and this study, N109 this study, and I153 [3,41]. Residues present in b-
strands are indicated with squares. Other residues are presented as circles.
doi:10.1371/journal.pone.0006739.g001
Table 2. OmpA peptide insertions in loop 2 as reported in literature as well as this study.
Name Target Loop AA Sequence 2/+ Charge Reference
8 AA pronase L2 8 NWLGRMPY 0/1 [18]
21 AA proteinase K L2 21 AGMQAYRIRA RYPGILFSRPA 0/4 [3]
3xFLAG mAb M2 L2/3 22 DYKDHDG-DYKDHDI-DYKDDDDK 211/4 This study
2xmyc mAb 9E10 L2/3 20 EQKLISEEDL EQKLISEEDL 28/2 This study
SA-1 Streptavidin L1 15 RLEICQNVCYYLGTL 21/1 [5]
doi:10.1371/journal.pone.0006739.t002
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similar to the growth curve of uninduced cells.
The induction experiment was performed for all the OmpA TM
domain variants and the results are listed in Table 3. It can be
concluded that in strain LMC500, induction of the loop 2 (FLAG/
myc), and to a lesser extent, the loop 1 (SA-1), but not the loop 3
(FLAG/myc) insertions caused a lag phase of 30–60 min after
which growth continued normally. Surprisingly, this lag phase was
absent both in MC1061 and in MC1061DOmpA. Induction with
0.3 mM IPTG of the loop 2 (FLAG), or loop 1 (SA-1) in these
strains had no effect on the growth rate at all. Because in LMC500
and MC1061, similar protein levels were detected on immuno-
blots, it appears that strain MC1061 and its derivative
MC1061DOmpA are more able to cope with the perturbation
caused by the induction (see also discussion).
Expression of OmpA-177 loop insertion proteins
Samples, harvested at the end of the induction experiment
described above were analyzed by SDS-PAGE and immunoblot-
ting. For the FLAG and myc constructs, a blot is shown in Figure
S2. Based on the immunoblots it was clear that all four variants
(either FLAG or myc in Loop 2 or 3) were expressed, no
degradation bands were observed, and all ran at a similar height
that was retarded with respect to their calculated molecular weight
(approx. 3–4 kDa). This was also observed for full-length
constructs that carried a FLAG insertion (see below). The reduced
mobility on gel was attributed to the high amount of negative
charge in the FLAG and myc peptides. Unexpectedly, unpro-
cessed (precursor) proOmpA-177 was also detected in uninduced
samples as well as in induced samples expressing either FLAG or
myc in loop 3 (see also Figure S3). The difference in protein levels
between induced and uninduced samples was a factor 2–5 fold (all
protein levels were determined from immunoblot by densitometry
using ImageJ, data not shown). Without induction, for FLAG as
well as myc, about 25% of the loop 3 constructs detected were not
processed.
Induced OmpA-177 without loop insertion was directly visible
on a Coomassie Brilliant Blue (Coomassie) stained SDS-PAGE (see
Figure 3) and could be detected on immunoblot using a polyclonal
antibody against OmpA, but the band was very weak compared to
endogenous (full-length) OmpA (data not shown). From this, we
conclude that this polyclonal antibody primarily recognizes the
periplasmic domain of OmpA. Also, an attempt was made to
detect the streptavidin binding peptide SA-1 construct on blot
using a Streptavidin-HRP conjugate, but only the endogenous
cytoplasmic biotinylated biotin carrier protein BCCP was detected
(data not shown). Apparently, streptavidin does not bind
sufficiently strong to the denatured conformation of SA-1.
To be able to directly compare the amounts of protein in the
membrane, membrane fractions were isolated of cells expressing
the various OmpA TM domain variants (Figure 3). Induction of
both OmpA-177 and OmpA-177 SA-1 constructs resulted in
strong bands at roughly their expected height (calculated MW of
OmpA-177 is 19.3 kDa and of OmpA-177 SA-1 is 21.1 kDa).
Surprisingly, no bands could be identified that corresponded to the
FLAG or myc constructs.
To determine how much of the expressed construct is present in
the envelope fractions put on gel, we compared soluble (S) to
membrane (M) fractions. Although not visible on a Coomassie
stained gel, immunoblots of the fractions showed that the FLAG
and myc constructs were present, and fractionated predominantly
to the membrane fraction (Figure S3). We conclude that these
constructs are present in the cell at greatly reduced amounts (less
than 10% as judged from the Coomassie stained gel) compared to
wild type OmpA-177 or the OmpA-177-SA1. This could either be
Figure 2. Growth curves of cells expressing OmpA TM domain
variants: effect of IPTG induction. Shown are growth curves of
OmpA-177 variants with and without induction with IPTG. Note that
FLAG inserted in Loop 2 causes a growth delay upon induction whereas
FLAG inserted in Loop 3 does not. Similar behavior was observed for the
myc tag (data not shown, see also Table 3). Cultures grown over night
at 37uC were diluted 500 times in fresh TY medium. At an OD600 of 0.2,
IPTG was added to a final concentration of 0.3 mM when indicated.
Crosses represent control cells harboring the empty plasmid (pTHV037).
Squares represent cells that express OmpA-177 with a FLAG insertion in
loop 2 (Open: without IPTG, Filled: with IPTG). Circles represent cells
that express OmpA-177 with a FLAG insertion in loop 3 and IPTG added.
doi:10.1371/journal.pone.0006739.g002
Table 3. Growth and molecular mass as detected on immunoblot after induction with 0.3 mM IPTG of LMC500 expressing OmpA
proteins with loop insertions.
Construct Peptide Location Growth after induction Mass on PAGE/blot (kDa)
MD005 none NA ++ 19
GV2 3xFLAG loop 2 22 25
GV4 3xFLAG loop 3 + 25 and 27
GV1 2xmyc loop 2 22 25
GV3 2xmyc loop 3 + 25 and 27
GV28 SA-1 loop 1 – 21
‘‘Growth after induction’’ indicates the presence and extent of a lag phase after adding inducer (++ no lag phase, 22 strong lag phase).
doi:10.1371/journal.pone.0006739.t003
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tags), due an increased degradation rate (see also below) or both.
Role of the periplasmic domain
To our knowledge, all OmpA loop insertions reported in the
literature have been made in full-length OmpA. To establish
whether the periplasmic domain might play a role in preventing a
reduction in protein levels after FLAG or myc insertion in the
transmembrane domain, full-length constructs were made for the
FLAG epitope in loop 2 and 3, and the SA-1 insertion in loop 1.
These constructs were transformed to LMC500 and MC1061
DOmpA and were subjected to the same induction experiment as
for the OmpA TM domain variants. Without induction, all full-
length constructs grew normally in both genetic backgrounds.
After induction, the growth rate remained unaffected for all full-
length OmpA loop insertion constructs in the MC1061 DOmpA
background whereas expression in LMC500 resulted in growth
curves similar to those obtained for the OmpA-177 constructs
(only tested for the loop 3 FLAG insertion).
The full-length constructs were detected both on Coomassie
stained gel (Figure 4A) as well as on immunoblot using a
polyclonal antibody that recognizes the periplasmic domain of
OmpA (Figure 4B, Figure S4). As with the FLAG OmpA-177
proteins, full-length OmpA FLAG constructs had a higher
apparent molecular weight than calculated. Comparing soluble
to membrane fractions using immunoblots yielded similar results
as for the OmpA-177 variants, with the majority of each construct
fractionating to the membrane fraction, except loop 3, which was
divided over the soluble and membrane fraction (Figure S4).
Again, the FLAG constructs appear greatly reduced compared
to both the OmpA without insertion and the OmpA with an SA-1
insertion, all expressed from plasmid. The intensities of the anti-
OmpA bands from Figure S4 were quantified using ImageJ and
plotted as bar graphs in Figure 5. Together with Figure 4A, it can
be concluded that full-length OmpA constructs with FLAG
insertions either in loop 2 or loop 3, are present at approximately
5–10% compared to full-length OmpA without insertion or the
full-length OmpA carrying a SA-1 insertion, respectively.
Apart from intact construct, the immunoblots probed with anti-
OmpA antibody revealed a strong band around 17 kDa (the
expected size of the periplasmic domain) that fractionates to the
soluble fraction (Figure 4B). This band was absent from samples
containing induced full-length OmpA without insertion and
weakly detected in induced full-length OmpA with the SA-1
insertion (data not shown). From this we conclude that the
degradation band is specific and that it is related to the reduced
protein levels of the FLAG constructs. In addition, the FLAG
constructs were detected using anti-FLAG antibody (Figure S4 and
not shown). The 17 kDa degradation band did not react with anti-
FLAG (the smallest degradation band detected with anti-FLAG
ran around 27 kDa). Apparently, the periplasmic domain of
OmpA was cleaved from the TM domain and the latter was to a
large extent degraded.
To test whether the 17 kDa degradation band was present in
periplasmic aggregates, we fractionated the cells into soluble
periplasmic contents and insoluble pellet by osmotic shock (See
Figure S6 and Materials and Methods S1). We find that the
degradation band was not aggregated but present in the soluble
periplasmic fraction, consistent with the idea that the FLAG/myc
OmpA variants are to a large extent degraded by periplasmic
proteases.
Taken together, it can be concluded that both the full-length
and the OmpA-177 constructs with a FLAG insertion are present
in greatly reduced amounts, compared to without insertion or with
a SA-1 insertion. Therefore, addition of the periplasmic domain
does not improve protein levels of the FLAG insertion.
Furthermore, the reduction in protein levels is, at least partly,
caused by degradation, as observed on immunoblots.
OM incorporation of truncate and full-length OmpA
constructs
To study whether the OmpA variants, present in the membrane
fraction, have obtained their native form, we examined their heat-
modifiability. The native form of the OmpA TM domain is a
compact b-barrel that has a particularly tight fold with a half life of
30 min when heated to 72uC in 2% SDS [23]. When heated in
Figure 3. OmpA-177 TM domain variants containing FLAG or myc, but not SA-1 are present at reduced levels. Shown is a Coomassie
stained 15% SDS-PAGE containing membrane fractions. Fractions corresponding to 1 ml OD600 of 0.625 cells were loaded. IPTG was either absent (2),
or added during exponential growth at an end concentration of 0.3 mM (+). Membrane fractions were isolated both from LMC500 (OmpA+) and
MC1061 DOmpA. Open circles indicate the expected position of the FLAG and myc variants as determined from immunoblotting (e.g. Fig. S3). The
asterisk indicates an unknown band that did not react with anti-myc on immunoblot. The positions of the OmpC/OmpF band, as well as the
endogenous OmpA band are indicated.
doi:10.1371/journal.pone.0006739.g003
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soluble without unfolding and migrates faster through the gel
(30 kDa) relative to its denatured form, which runs at the expected
molecular weight (35 kDa). This effect is called heat modifiability
[14] and it is a general property of b-barrels. Various techniques
have been used to confirm that the 30 kDa form corresponds to
the native fold of OmpA (for references consult [24]. It is generally
assumed that in vivo, the native form of OmpA is generated only
after proper insertion into the outer membrane (Ried, 1994).
Cell membranes containing IPTG-induced OmpA-177 or
OmpA-177 SA-1 proteins, expressed in LMC500 or MC1061
DOmpA were either heated in sample buffer for 5 min at 99uCo r
for 15 min at 50uC, then applied on gel, separated by SDS-PAGE
and stained with Coomassie (Figure 6). Note that both OmpC and
OmpF do not become soluble at 50uC and are therefore only
visible in samples heated at 99uC [10]. As expected, the
endogenous OmpA of LMC500 is fully heat-modifiable. Further-
more, the OmpA-177 protein, but not the OmpA-177 containing
the SA-1 insertion, shows the aberrant heat-modifiability already
observed in the literature for OmpA-171 [10], where the folded
protein migrates slower than the unfolded protein (see also
discussion). Finally, the OmpA-177 SA-1 protein is also fully heat-
modifiable. We conclude that the majority, if not all, of both
constructs have reached their native form.
For the FLAG and myc constructs, because of their low levels in
the cell, immunoblotting was used to visualize their heat-
modifiability (Figure 7). The OmpA TM domain constructs with
FLAG or myc are all predominantly heat-modifiable (Figure 7A,
indicated ‘‘mature’’). As expected, the loop 3 precursor bands
(indicated ‘‘unprocessed’’), present in the membrane fraction, are
not at all heat-modifiable. Also a full-length OmpA construct
carrying a loop 2 FLAG insertion was found to be fully heat-
modifiable (Figure 7B). We conclude that all FLAG and myc
constructs are at least partially heat-modifiable, and thus can be
properly incorporated in the outer membrane.
Surface display of loop insertions: fluorescent labeling of
cells
To determine the accessibility on the cell surface of the inserted
antigenic peptides, both fixed and living cells were labeled. Cells
carrying the FLAG and myc in either loop 2 or 3 of OmpA-177
Figure 4. The periplasmic domain does not stabilize the TM domain and FLAG constructs are degraded. Left panel: Coomassie stained
15% SDS-PAGE. Membrane fractions corresponding to 1 ml OD600 of 0.625 cells were loaded. IPTG was either absent (2), or added during
exponential growth at an end concentration of 0.3 mM (+), or 1 mM (++). Envelopes were isolated from MC1061DOmpA. Open circles indicate the
position of the expressed constructs. The position of the OmpC/F band is indicated. The asterisks indicate a degradation band that reacted with anti-
OmpA. Right panel: full-length OmpA with a loop 2 FLAG insertion induced with 0.3 mM IPTG, fractionated in total, soluble and membrane fraction.
The immunoblot was probed with anti-OmpA (1:10000). The large degradation band at around 17 kDa is clearly visible, and was almost completely
soluble. The strain was MC1061DOmpA.
doi:10.1371/journal.pone.0006739.g004
Figure 5. Comparison of protein levels of OmpA with and
without inserted peptides. FLAG insertions, either in Loop 2 or 3, are
present at approx. 5–10% relative to either the full-length OmpA
without insertion or the full-length OmpA with a SA-1 insertion in Loop
1. The levels were quantified from immunoblots by densitometry using
ImageJ and are normalized relative to the stronger band. Both total cell
lysates and membrane fraction were quantified. For 3xFLAG in Loop 3,
compared with full-length OmpA without insertion, no IPTG was added.
For 3xFLAG in Loop 2, compared with SA-1 in Loop 1, constructs were
induced with 0.3 mM IPTG.
doi:10.1371/journal.pone.0006739.g005
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monoclonal anti-FLAG or monoclonal anti-myc. As a negative
control, the primary antibody was left out, and no fluorescence
was observed for any of these samples. All four constructs were
detected on the bacterial cell surface (Figure S5). Loop 2 insertions
show more staining at the poles, whereas loop 3 insertions are
more homogeneous.
Living cells were labeled using a biotinylated variant of the anti-
FLAG antibody. Labeling of living cells was performed because it
was found that fluorescent streptavidin (needed for the SA-1
peptide) penetrated fixed cells to show a nucleoid-like staining
(data not shown). The cells could be fixed after labeling to preserve
the staining.
Results of labeled, uninduced cells carrying either OmpA-177
FLAG (loop 3) or the full-length OmpA-FLAG (loop 3) showed
that both have comparable levels of antibody-accessible FLAG
epitope on their surface (Figure 8A, B). This provides further
evidence that adding the periplasmic domain does not result in
increased stability of the protein. The limited increase in
fluorescence after induction correlates with a modest increase of
intact protein, and a larger increase of the 17 kDa degradation
band as detected on immunoblot (data not shown).
Finally, living LMC500 cells expressing OmpA-177-SA1 were
directly labeled with fluorescent streptavidin, fixed and imaged
(Figure 8C). To be able to compare with and without induction
directly, a short exposure time (150 ms) was chosen. Without
induction staining was homogeneous along the perimeter of the
cells. After induction (and after recovery from the lag phase that
occurs in LMC500, see earlier), fluorescence increased markedly,
and during labeling, strong streptavidin-mediated cross-linking
between cells occurred, leading to clumps. Overall, we conclude
that all the constructs are detected on the cell surface, but for
Figure 6. The OmpA TM domain constructs OmpA-177 and OmpA-177 SA-1 are fully heat modifiable. A Coomassie stained gel
containing membrane fractions (corresponding to 1 ml OD600 of 0.625 cells) from cells expressing either OmpA-177 or OmpA-177 SA-1 constructs
induced with 1 mM (OmpA-177) or 0.3 mM (OmpA-177 SA-1) IPTG, either in LMC500 (OmpA+) or MC1061 DOmpA. The samples were either heated
in sample buffer for 5 min at 99uC or for 15 min at 50uC. Folded proteins are prefixed with f- and unfolded proteins are prefixed with u-.
doi:10.1371/journal.pone.0006739.g006
Figure 7. OmpA-177 domain variants with FLAG or myc epitopes and a full-length OmpA variant with a FLAG epitope are
predominantly heat-modifiable. Cell envelopes of various OmpA-177 TM domain variants (A) and the full-length Loop 2 FLAG construct (B) were
either heated in sample buffer for 5 min at 99uC or for 15 min at 50uC, before being separated on a 15% SDS-PAGE and immunoblotted. Indicated
are: (p) processed, unfolded, (m) matured, properly folded and (u) unprocessed, unfolded. In (A) 0.1 mg/ml anti-FLAG was used for the induced Loop 2
construct, and 1 mg/ml anti-myc and 0.5 mg/ml anti-FLAG were used for the uninduced Loop 3 constructs. In (B), 1:10000 anti-OmpA, and 0.1 mg/ml
anti-FLAG was used.
doi:10.1371/journal.pone.0006739.g007
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due to degradation, whereas for SA-1, both efficient labeling and a
strong effect of induction on the surface display is observed.
Discussion
In this work we have characterized peptide insertions in the
OmpA protein, both in TM domain constructs (OmpA-177) and
full-length constructs. As insertions we used the popular FLAG
and myc epitopes, and a streptavidin binding peptide SA-1. It has
been demonstrated that similar-sized peptides can be inserted in
loop 2 of OmpA without reduction in protein levels or membrane
incorporation [3,18]. Unexpectedly, introducing a FLAG or myc
peptide at this location in the OmpA protein reduced the protein
levels with approximately 90% (Figure 3, Figure 5). However, the
majority of the intact protein was inserted properly in the OM, as
judged by its heat-modifiability (Figure 7A). In contrast, insertion
of the SA-1 peptide in loop 1 did not reduce protein levels, similar
to the reported insertions in loop 2 (Table 2). These results have
been summarized in Table 4.
It could be argued that the observed differences are due to over-
expression of the proteins. However, our expression vector (a
weakened pTrc99A [16]) produces less than 5?10
3 proteins in the
absence of IPTG [25], and already at these low expression levels
the marked difference in protein level between OmpA with a
FLAG insertion and OmpA without insertion is observed
(Figure 5). This suggests that introducing the FLAG epitope leads
to an intrinsically reduced protein level, independent of the
induction level.
What could be the reason of the observed reduction in protein
levels of the FLAG and myc constructs? Both epitopes are highly
charged (Table 2). In addition, both the FLAG and myc epitopes
are effectively negatively charged, and therefore might interact
unfavorably with the negatively charged LPS in the OM, or with
the YaeT/BamA protein complex responsible for OM insertion
[26]. We speculate that a reduced rate of OM incorporation might
cause a buildup of unincorporated (misfolded) OmpA proteins,
whose subsequent degradation would explain the reduced cellular
levels of the FLAG and myc constructs reported here.
Although the number of tested insertions thus far is small, one
might speculate that the abundant charge of the inserted epitopes
is the cause of the degradation and consequently, of the reduced
display levels. Negative effects on OM incorporation after
insertion of highly charged peptides have also been reported for
outer membrane protein PhoE [27]. It was found that an 20-mer
insertion containing 10 positively charged residues, as well as a 28-
mer insertion containing 6 negative and 2 positively charged
residues were not correctly incorporated in the OM [27], whereas
a PhoE variant with a VP1 epitope inserted at the same location
was incorporated in the OM at normal protein levels [28,29]. It
might thus be worth testing more systematically the effect of
charged peptide insertions on OMP incorporation in systems that
are used for display and/or screening purposes.
One may subsequently ask to what extent differences in display
levels affect the application of the OmpA scaffold in, for instance,
random library screening using FACS. Whether variations in
display efficiency affect a particular screening method is
determined by the detection sensitivity and specificity of that
method. Interestingly, the FLAG anti-FLAG M2 epitope/
antibody combination has been subjected to epitope mapping
with MACS and FACS using the related OmpX display system,
and the consensus recognition sequence DYKDxD [30,31] was
successfully recovered [4]. This indicates that selection for a
sequence containing four charged residues in a surface-displayed
library of random 15-mers is possible. Unfortunately, whether the
isolated clones had reduced display levels was not determined. It
will be interesting to assess if peptides with more (mostly negative)
charge such as 3xFLAG or 2xmyc can also be selected for with
FACS, and to what extent the various selection methods are
affected by display biases.
Unexpectedly, in exponentially growing cells without IPTG,
about 25% of the loop 3 insertions are not processed. Since OmpA
is mostly post-translationally translocated to the periplasm via the
Sec system [32], in these cases perhaps some tertiary structure
forms in the cytoplasm that delays, or interferes with, its
translocation [33]. However, induction of constructs with FLAG
in loop 2 or loop 3 results in similar amounts of processed OmpA
(Figure S2), and in similar amounts of FLAG epitope detected on
the bacterial surface (Figure S5). This suggests that after processing
and release into the periplasm, both proteins behave in a similar
way, and we conclude that the adverse effects of the FLAG and
myc epitopes on protein levels do not appear to be loop specific.
Surprisingly, induction of either (FLAG or myc) loop 2
constructs or the OmpA-177-SA1 in LMC500 (MC4100 lysA)
affects growth rate profoundly in a transient manner. It is difficult
to understand that loop 2 FLAG/myc and loop 1 SA-1 constructs
cause a similar effect on growth rate in LMC500, since their
amounts differ 10-fold. Perhaps the cell regulates the amount of
proteins in the OM that are tolerated (little in the case of FLAG/
myc, a lot in the case of SA-1). When IPTG induction disturbs this
balance, the observed lag period of 30 min might reflect a period
in which the cell adapts and restore this balance, after which the
cells continue growth.
Accumulation of misfolded OMPs in the cell envelope causes
the activation of the s
E controlled extracytoplasmic stress response
[34] that down-regulates OMP expression ([35]). Indirect evidence
for s
E activation upon IPTG induction of our OmpA loop
insertion variants comes from the membrane fractions shown in
Figures 3 and 4, where OMP expression (OmpC/F and OmpA) is
Table 4. Comparison of similar-sized peptide tags inserted in OmpA.
Peptide Insertion size (AA) Protein levels (%)
a Proper OM incorporation
b Surface display peptide
c
None 0 100 yes NA
3xFLAG 22 5–10 yes yes
2xmyc 20 5–10 yes yes
SA-1 15 90–100 yes yes
aRelative protein levels compared to OmpA without tag inserted (first row in this table, set at 100%).
bProper OM incorporation deduced from proper b-barrel formation using the heat-modifiability assay.
cSurface display of the inserted tag deduced from fluorescent labeling of intact cells.
doi:10.1371/journal.pone.0006739.t004
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loop insertion variants.
In the different genetic background of strain MC1061 and its
derivative MC1061 DOmpA, expression levels were similar to
LMC500, but the growth rate was unaffected upon IPTG
induction (data not shown). It has been shown that the s
E
transcription factor is also controlled by intracellular ppGpp levels
[36]. MC1061 has the spoT1 mutation, that abolishes the
ppGppase activity of SpoT and results in increased levels of
(p)ppGpp (Cashel, 1996). This could offer an explanation for the
observed robustness of MC1061 towards overexpression of the
OmpA loop insertion constructs. If MC1061 is better able to cope
with folding stress in the periplasm (e.g. by having its stress
response genes already expressed, or in higher levels), the balance
can be restored immediately, without disturbing the growth rate.
Whatever the molecular mechanism may be, our results indicate
that MC1061 is a strain of choice when over-expressing
engineered outer membrane proteins such as OmpA.
Finally, our results provide insight on the aberrant heat-
modifiability observed for 8-stranded b-barrels such as OmpA-
171, OmpA-177 and NspA ([10,37] and this study). Heat-
modifiability has been termed ‘‘aberrant’’ when the unfolded
form migrates faster through the gel compared to the folded form.
Surprisingly, for the OmpA-177 insertion variants (SA-1, FLAG or
myc) heat-modifiability is ‘‘normal’’ again (Figure 6). Comparing
the mobility of OmpA-177 to OmpA-177-SA-1, we find that the
folded barrels run at almost similar height, as if the extra residues
of SA-1 were absent, whereas after boiling, OmpA-177-SA-1 is
retarded with respect to OmpA-177 with an amount correspond-
ing to their difference in molecular mass. In other words, the
additional residues inserted in the exterior loop have a stronger
impact on the unfolded form than on the folded form. These
results suggest that as more and more residues are added to the
OmpA-171 TM domain, the relative positions between the folded
and unfolded domains first decrease until they are equal, before
increasing again to appear as ‘‘normal’’ heat-modifiability. This
predicts that for some rare OMPs, it would seem as if they would
not have any heat-modifiability at all.
Conclusions
Most bacterial display studies focus on either identifying novel
scaffolds or novel applications. In this work, a thorough analysis
was performed of constructs that contain similar-sized peptides
inserted into the OmpA display scaffold. The effect of their
expression on E. coli growth, as well as their relative amount, sub-
cellular localization, folding state and surface accessibility has been
determined. In doing so, we believe that several useful observa-
tions have been made that are relevant for the fields of surface
display, (outer) membrane protein over-expression and purifica-
tion as well as for applications that make use of bacteria as antigen-
displaying whole-cell adsorbents.
First, we conclude that OmpA displays not all small peptides
equally efficiently, since the highly charged and hydrophilic
3xFLAG and 2xmyc epitopes reduce protein levels 10-fold due to
degradation by periplasmic proteases. Second, the growth curves
obtained after inducing high-level expression of the OmpA epitope
variants in two standard laboratory strains MC4100 (LysA) and
MC1061 suggest that strain MC1061 is a strain of choice when
expressing OMPs in large amounts in E. coli. Finally, our
observation that the heat modifiability of the OmpA TM domain
can be changed from ‘aberrant’ to normal by insertion of small
epitopes predicts that some b-barrels might not exhibit significant
heat-modifiability at all.
Supporting Information
Figure S1 Predicted protein structures by SWISS-MODEL of
the OmpA transmembrane domain before and after epitope
insertion. PDB entries 1g90.pdb, 1bxw.pdb and 1qjp.pdb were
used to build the model. (A) OmpA-177 model. (B) OmpA-177
model with 2xmyc inserted in loop 2 after G70. (C) OmpA-177
model with 3xFLAG inserted in loop 3 after N109.
Found at: doi:10.1371/journal.pone.0006739.s001 (1.28 MB TIF)
Figure S2 Detection of OmpA-177 TM domain variants with
inserted 3xFLAG or 2xmyc peptides on immunoblot. Expression
of the variants was induced in LMC500 with 0.3 mM IPTG. From
left to right: OmpA-177 loop 2 myc, OmpA-177 loop 2 FLAG,
OmpA-177 loop 3 myc and OmpA-177 loop 3 FLAG. For loop 3
variants, unprocessed protein is also present. Left panel: anti-
FLAG (3 mg/ml), right panel: anti-myc (3 mg/ml). For this blot, a
12% SDS-PAGE gel percentage was used.
Found at: doi:10.1371/journal.pone.0006739.s002 (0.82 MB TIF)
Figure 8. Detection of the inserted peptides on the cell surface.
Fluorescently labeled cells expressing (A) FLAG in loop 3 of OmpA-177,
(B) FLAG in loop 3 of OmpA (full-length), or (C) SA-1 in loop 1 of OmpA-
177. Cells were grown in TY medium either without IPTG or with
0.3 mM IPTG added and induced for 2 hours before labeling. Exposure
times: (A, B) 1 s, (C) 150 ms. Strain was LMC500. Scale bar dimensions
are 1 by 2 mm.
doi:10.1371/journal.pone.0006739.g008
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nantly present in the membrane fraction. Total cell lysate (T) was
fractionated into soluble (S) and membrane (M) fractions. Shown
are immunoblots of constructs OmpA-177 loop 2 FLAG (induced),
OmpA-177 loop 3 myc (uninduced), and OmpA-177 loop 3
FLAG (uninduced). Strain is LMC500, except for loop 2 FLAG,
where results from strain LMC500 and MC1061DOmpA are
shown. Only the relevant portions of the blot are shown. Black line
indicates 25 kDa marker band. Antibody concentrations used
were 1 mg/ml (anti-myc), and 0.1 mg/ml or 0.5 mg/ml (anti-
FLAG) for induced or uninduced FLAG, respectively.
Found at: doi:10.1371/journal.pone.0006739.s003 (0.42 MB TIF)
Figure S4 The full-length OmpA constructs (except loop 3
FLAG) fractionate predominantly to the membrane fraction. Total
cell lysate (T) was fractionated into soluble (S) and membrane (M)
fractions. Shown are immunoblots of full-length OmpA constructs
carrying a FLAG insertion in loop 2 (d) or loop 3 (c), and an SA-1
insertion in loop 1 (e). Strain was MC1061DOmpA. As controls,
fractions of LMC500 (endogenous OmpA, OmpA+) (a), and
OmpA expressed from plasmid in MC1061DOmpA (b) are shown.
Only the relevant portions of the blot are shown. Black line
indicates 37 kDa marker band. For the wild type OmpA and
induced constructs, a 1:10000 dilution was used for the polyclonal
antibody against OmpA. For the uninduced construct, a 1:1000
dilution was used. Anti-FLAG was used for the induced and
uninduced FLAG constructs at 0.1 mg/ml and 1 mg/ml, respec-
tively. Band intensities in the anti-OmpA blots (b) and (c), and (d)
and (e) can be compared directly. Their relative intensities,
quantified using densitometry with ImageJ, are shown in Fig. 5.
Found at: doi:10.1371/journal.pone.0006739.s004 (1.10 MB TIF)
Figure S5 Myc and FLAG epitopes are detected on the surface
of cells expressing OmpA-177 TM domain variants. Cells induced
with 0.3 mM IPTG for expression of OmpA-177 containing either
FLAG in loop 2, myc in loop 2, FLAG in loop 3 or myc in loop 3,
were fixed and immuno-labeled with antibodies against FLAG or
myc. The scale bar corresponds to 2 mm. Image exposure time was
470 ms.
Found at: doi:10.1371/journal.pone.0006739.s005 (2.56 MB TIF)
Figure S6 The 17 kDa OmpA degradation band fractionates to
the soluble periplasmic fraction. Soluble periplasmic fractions (s)
and insoluble cell pellet (i) were prepared as described in
Supplementary Materials and Methods. Shown are immunoblots
of the strain MC1061DOmpA containing constructs expressing
full-length OmpA without tag insertion (pGI9) and full length
OmpA with a 3xFLAG inserted in Loop 2 (pGV32). The latter
protein is present at the expected height in the insoluble fraction,
as expected for a properly assembled OM protein. The stronger
17 kDa degradation band is present in the soluble periplasmic
fraction instead. Only the relevant portions of the blot are shown.
The soluble periplasmic protein MBP (40 kDa), inducible by
growth on maltose (0.2%), was used as a fractionation marker. The
polyclonal anti-OmpA antibody was used in a 1:10000 dilution
(upper blot) and the monoclonal anti-MBP antibody (Abcam,
#ab65) was used at a concentration of 1.8 mg/ml (lower blot).
Found at: doi:10.1371/journal.pone.0006739.s006 (1.06 MB TIF)
Materials and Methods S1 Contains detailed plasmid cloning
steps and the fractionation protocol for Figure S6.
Found at: doi:10.1371/journal.pone.0006739.s007 (0.03 MB
DOC)
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